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INCIDENCE	OF	POSTOPERATIVE	THROMBOSIS	IN	CHILDREN	WITH	SURGICAL	
AND	NON-SURGICAL	HEART	DISEASES	
KATHERINE	M.	GARDELLA	ABSTRACT	
Objectives:	Congenital	heart	disease	or	CHD	is	a	condition	that	affects	8	out	of	every	1,000	 newborns.	 Every	 year	 more	 than	 35,000	 newborns	 are	 diagnosed	 with	 a	congenital	heart	disease	in	the	United	States.	Neonates	and	children	with	congenital	heart	 disease	 are	 at	 increased	 risk	 for	 thrombotic	 events,	 especially	 those	with	 a	single	ventricle	physiology.	The	objective	of	 this	study	was	to	assess	the	 incidence	and	to	identify	the	predictors	of	thrombosis	in	neonates	and	children	with	surgical	and	non-surgical	heart	diseases.		
Methods:	We	 performed	 a	 retrospective	 analysis	 of	 the	 Health	 Care	 and	 Cost	 Use	Project	 Kid’s	 Inpatient	 Database.	 Neonates	 and	 children	 with	 a	 congenital	 heart	disease	were	identified	using	the	international	classification	of	disease,	9th	revision,	clinical	 modification	 (ICD-9	 CM)	 diagnostic	 codes,	 and	 grouped	 into	 two	 sub-categories	 of	 surgical	 heart	 and	 non-surgical	 heart	 diseases.	 These	 groups	 were	further	divided	into	four	types	of	lesions:	septal	defects,	single	ventricle	physiology,	right	ventricle	outflow	tract	obstruction,	and	left	ventricle	outflow	tract	obstruction.	Demographic	 characteristics,	 the	 presence	 of	 co-morbidities,	 the	 incidence	 of	 any	thrombotic	events,	mortality	rate,	and	the	presence	of	additional	complications	such	as	acute	kidney	injury,	sepsis,	neurologic	complications,	the	need	for	extracorporeal	membrane	oxygenation	or	ventricular	assist	device	were	also	collected	using	ICD-9	
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CM	codes.	After	propensity-matched	analysis,	neonates	and	children	with	a	surgical	congenital	 heart	 disease	 were	 compared	 with	 those	 with	 a	 non-surgical	 heart	disease.	We	used	uni-	and	multivariable	 logistic	regression	analysis	 to	 identify	 the	predictors	associated	with	the	incidence	of	thrombotic	events	in	both	sub-group.		
Results:	 In	 children	 with	 surgical	 heart	 disease,	 the	 incidence	 of	 thrombosis	 was	3.90%,	 compared	 with	 2.13%	 in	 children	 with	 non-surgical	 heart	 disease.	Furthermore,	 those	with	 single	 ventricle	 physiology	 (surgical	 2.13%;	 non-surgical	3.41%)	 or	 right	 ventricle	 outflow	 tract	 obstruction	 (surgical	 1.54%;	 non-surgical	1.66)	 had	 the	 highest	 incidence	 of	 thrombosis.	 In	 addition	 to	 demographic	characteristics	(e.g.	age)	and	the	type	of	congenital	heart	disease,	we	observed	that	extracorporeal	membrane	 oxygenation	 (ECMO)	 or	 ventricular	 assist	 device(VAD),	the	presence	acute	kidney	 injury,	sepsis,	and	coagulopathy	were	strong	predictors	for	the	development	of	thrombotic	events.	
Conclusions:	 Children	 with	 both	 surgical	 and	 non-surgical	 heart	 disease	 have	 an	increased	risk	for	thrombotic	events,	but	those	with	a	single	ventricle	physiology	or	a	right	ventricle	outflow	tract	obstruction	had	a	further	increased	risk.			 	
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INTRODUCTION			 Congenital	 heart	 disease	 or	 CHD	 is	 a	 condition	 that	 affects	 8	 out	 of	 every	1,000	 newborns	 (National	 Heart,	 Lung,	 and	 Blood	 Institute,	 2013).	 Every	 year,	 a	diagnosis	 of	 congenital	 heart	 disease	 is	 made	 in	 more	 than	 35,000	 babies	 in	 the	United	 States	 (National	 Heart,	 Lung,	 and	 Blood	 Institute,	 2013).	 Congenital	 heart	disease	can	 take	many	 forms;	 it	 can	 range	 from	a	 ‘simple’	malformation	 that	does	not	require	any	intervention,	and	will	resolve	within	the	first	6	months	of	 life	(e.g.	atrial	 septal	 defect	 or	 ventricular	 septal	 defect)	 to	 an	 extremely	 complex	 disease	that	will	 require	 a	 long	 series	 of	 surgical	 interventions.	 Examples	 of	 simple	 CHDs	would	 include	 atrial	 and	 ventricle	 septal	 defects,	 patent	 ductus	 arteriosus,	 or	narrowed	 valves.	 Complex	 CHDs	 can	 include	 tetralogy	 of	 Fallot,	 single	 ventricle	defects,	 hypoplastic	 left	 heart	 syndrome,	 transposition	 of	 great	 arteries,	 or	 aortic	arch	anomalies	(National	Heart,	Lung,	and	Blood	Institute,	2013).		
Septal	Defects	(SD)		 Septal	defects,	or	holes	in	the	heart,	are	simple	congenital	heart	defects	that	correspond	 to	 different	 forms	 of	 incomplete	 junction	 and	 closure	 of	 embryologic	structures	leading	to	abnormal	persistent	communication	between	the	left	and	the	right	sides	of	the	heart.	Such	communications	could	be	found	in	either	the	atrial	or	ventricular	septum	(National	Heart,	Lung,	and	Blood	Institute,	2013).	This	condition	will	 usually	 correct	 itself	 without	 the	 need	 for	 any	 surgical	 or	 interventional	procedures.	However,	in	the	absence	of	spontaneous	closure,	an	intervention	will	be	
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required	to	close	the	communication,	and	avoid	long-term	complications	associated	with	 this	non-physiologic	 shunt	of	 the	blood	 from	 the	 left	part	of	 the	heart	 to	 the	right	(e.g.	cardiomyopathy,	cardiac	failure,	pulmonary	artery	hypertension).	In	case	there	 is	 a	 need	 for	 an	 intervention	 to	 close	 the	 communication,	 the	 patient	 can	either	 undergo	 a	 surgical	 repair,	 corresponding	 to	 an	 open-heart	 surgery	 with	cardiopulmonary	bypass,	or	a	 closure	using	a	 interventional	 cardiology	 technique,	or	 a	 hybrid	 procedure	 using	 both	 techniques	 (Mayo	 Clinic,	 2014).	 Patients	 will	usually	require	an	 intervention	only	 if	 the	hole	 is	medium	or	 large	 in	size	because	they	have	a	higher	risk	of	not	closing	on	their	own	through	growth	(National	Heart,	Lung,	and	Blood	Institute,	2013).		 As	reported	by	the	National	Heart,	Lung,	and	Blood	Institute,	an	atrial	septal	defect	is	a	hole	in	the	wall	of	the	septum	that	separates	the	upper	chambers	of	the	heart	 (National	 Heart,	 Lung,	 and	 Blood	 Institute,	 2013).	 It	 is	 a	 congenital	 heart	disease	 that	has	 few,	 if	 any,	 symptoms.	A	ventricular	 septal	defect	 is	 a	hole	 in	 the	wall	 of	 the	 septum	 that	 separates	 the	 lower	 chambers	 of	 the	 heart.	 Unlike	 atrial	defects,	 having	 a	 ventricular	 septal	 defect	 will	 cause	 symptoms	 if	 it	 is	 large	 or	medium	in	size.	Because	of	the	large	opening	there	is	an	extra	workload	on	the	heart	and	 this	 can	 cause	 heart	 failure	 and	 poor	 growth	 along	with	 high	 blood	 pressure	(National	Heart,	Lung,	and	Blood	Institute,	2013).	
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Single	Ventricle	Physiology	(SVP)	 		 There	 are	 three	 common	 types	 of	 single	 ventricle	 defects;	 hypoplastic	 left	heart	 syndrome,	 pulmonary	 atresia	 with	 intact	 ventricular	 septum,	 and	 tricuspid	atresia.	 Single-ventricle	 heart	 defects	 are	 often	 diagnosed	 during	 pregnancy	 or	immediately	after	birth	(American	Heart	Association,	2015).	The	underlying	causes	of	single	ventricle	defects	are	usually	unknown	and	are	not	completely	modifiable.	Children	with	these	conditions	can	often	have	other	heart	defects	along	with	their	SVP	(American	Heart	Association,	2015).	Children	with	single	ventricle	physiology	are	 at	 an	 increased	 risk	 for	 short	 and	 long-term	 complications,	 both	 during	 the	perioperative	period	of	the	different	surgical	procedures	required	and	a	decreased	standard	of	 living	when	compared	to	other	patients	 in	 their	age	group	(Center	 for	Disease	 Control,	 2016;	 Idorn	 et.	 al.,	 2013).	 Neonates	 and	 children	 with	 SVP	 will	require	 a	 series	 of	 surgical	 procedures	 usually	 defined	 as	 follow:	 right	 modified	Blalock-Taussig	shunt	within	the	first	days	or	weeks	after	birth,	Glenn	procedure	at	the	age	of	3-6	months,	and	the	Fontan	surgery	usually	performed	at	the	age	of	2-3	years	 old.	 Even	 though,	 the	 introduction	 of	 this	 series	 of	 surgical	 procedure	 has	significantly	 improve	 survival	 in	 those	 patients,	 the	 procedures	 should	 be	considered	as	palliative	options,	with	a	congenital	heart	disease	that	will	never	been	completely	solved,	and	will	require	lifetime	medical	treatments.			Hypoplastic	 left	 heart	 syndrome	 (Figure	 1)	 is	 one	 of	 the	 most	 complex	diseases	 where	 the	 entire	 left	 side	 of	 the	 heart,	 and	 sometimes	 the	 aorta	 are	underdeveloped.	 Patients	 present	 with	 a	 severe	 cyanotic	 with	 poor	 peripheral	
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pulses,	 rapid	 breathing,	 and	 cold	 hands	 and	 feet	 to	 name	 a	 few	 symptoms	(Cincinnati	 Children’s	 Hospital,	 2013).	 As	 described	 above,	 such	 a	 SVP	 requires	three	palliative	 surgeries	 to	 allow	 for	 correct	blood	 to	 flow	 through	out	 the	body,	while	in	some	patients	a	heart	transplant	will	be	the	only	option.	The	three	palliative	surgeries	are	the	Norwood	procedure,	the	bi-directional	Glenn	shunt	procedure,	and	the	Fontan	procedure	(American	Heart	Association,	2015).		Between	birth	and	two	weeks	of	life	the	patient	will	undergo	the	first	of	three	palliative	surgeries	(Figure	4).	The	Norwood	procedure	(Figure	2)	is	carried	out	to	create	a	new	aorta,	of	normal	size,	and	a	shunt.	The	atrial	septum	is	opened	and	the	old	aorta	and	coronary	arteries	are	connected	to	the	new	enlarged	aorta.	There	are	two	 types	 of	 shunts	 typically	 used	 in	 the	 Norwood	 procedure,	 the	 right	modified	Blalock-Taussig	 shunt	 (RMBTS)	 or	 the	 right	 ventricle	 to	 pulmonary	 artery	 shunt	(RVPA).	 The	 Blalock-Taussig	 shunt	 is	 the	 original	 shunt	 that	was	 performed	with	success	 in	 this	 procedure	 (Center	 for	 Disease	 Control,	 2016).	 The	 RMBTS,	 is	 a	modified	approach	of	the	original	Blalock-Taussig	shunt,	and	is	created	between	the	right	 subclavian	 artery,	 and	 the	 right	 pulmonary	 artery	 to	 generate	 flow	 into	 the	pulmonary	 arteries.	 	 The	 RVPA	 shunt	 provides	 the	 same	 flow	 to	 the	 pulmonary	arteries	except	it	connects	the	pulmonary	artery	directly	to	the	right	ventricle	(Ohye	
et.	al.,	2010).	This	technique	is	not	routinely	used,	as	the	RMBTS	is	usually	preferred	(Ohye	et.	al.,	2010).			
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Figure	1:	Hypoplastic	Left	Heart	Syndrome.	As	seen	in	the	figure	the	left	ventricle	is	under	developed	along	with	the	aorta.	The	direction	of	the	blood	flow	causes	mixture	of	oxygenated	and	deoxygenated	blood	through	an	atrial	septal	defect.	(Adapted	from	Ohye	et.	al.,	2010)		
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Figure	2:	Comparison	of	MBT	shunt	and	RVPA	shunt.	The	raised	dashed	lines	represent	the	new	enlarged	aorta	and	new	connections.	The	shunts	are	whiter	 in	 color	 to	 emphasize	 the	different	 types	 of	 shunts	placements.	 The	only	 difference	 between	 the	 two	 surgeries	 is	 the	 type	 of	 shunt.	 (Adapted	from	Ohye	et.	al.,	2010)			
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	Following	 the	 Norwood	 procedure,	 between	 3	 to	 6	 months	 of	 age	 the	 bi-directional	 Glenn	 shunt	 procedure,	 or	 the	 hemi-Fontan	 procedure	 is	 performed	(Center	for	Disease	Control,	2016).	This	surgery	is	necessary	to	reduce	the	amount	of	 strain	 placed	 on	 the	 right	 ventricle.	 Creating	 a	 direct	 connection	 between	 the	superior	vena	cava	and	pulmonary	artery	,	which	reduces	the	workload	on	the	right	ventricle,	and	allows	the	oxygenation	of	the	venous	blood	before	it	goes	back	to	the	systematic	circulation.	Though	the	child	may	still	appear	cyanotic	the	survival	rate	is	about	90%	if	they	can	make	it	to	this	surgery	(Cincinnati	Children’s	Hospital,	2013).		Lastly,	between	2	and	3	years	the	patient	will	undergo	the	Fontan	procedure	(Figure	3),	where	 the	 the	 inferior	vena	cava	 is	 connected	 to	 the	pulmonary	artery	using	 a	 prosthetic	 tube	 .	 Following	 the	 completion	 of	 the	 Fontan	 procedure	 the	deoxygenated	 blood	 flows	 passively	 to	 the	 lungs	 and	 the	 patient	 is	 no	 longer	cyanotic	 (Center	 for	 Disease	 Control,	 2016).	 The	 Norwood	 procedure,	 has	 the	highest	 rate	 of	mortality	 of	 the	 three	 surgeries	 at	 a	 75%	 survival	 rate	 (Cincinnati	Children’s	Hospital,	2013).	Many	pediatric	patients	have	difficulty	making	it	through	to	 the	 next	 surgery.	 These	 patients	 may	 also	 not	 be	 able	 to	 complete	 the	 three	surgeries	and	need	to	receive	a	heart	transplant.	Patients	who	have	not	completed	the	 palliative	 surgery	 to	 correct	 their	 congenital	 heart	 disease	 often	 experience	failing	 circulation,	 acute	 cardiac	 failure,	 or	 respiratory	 failure.	 Extracorporeal	membrane	 oxygenation	 (ECMO)	 has	 been	 found	 to	 be	 a	 useful	 bridge	 to	 heart	transplant	or	surgery	for	these	patients	(Bautista-Hernandez	et.	al.,	2014).	While	it	
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has	been	found	to	be	helpful	in	getting	patients	through	to	their	next	surgery,	ECMO	is	not	without	its	complications.	In	a	study	performed	by	Tajik	et.	al.	(2008),	found	that	while	 there	was	a	higher	 survival	 to	discharge	of	12-23%	when	compared	 to	CPR	alone,	 there	were	high	 incidences	of	 complications.	These	 complications	 they	found	 were	 neurological	 and	 renal	 in	 nature	 and	 had	 a	 strong	 influence	 on	 the	survival	of	the	patient	(Tajik	et.	al.,	2008).		
	 Pulmonary	 atresia	 is	 characterized	 by	 the	 absence	 of	 the	 pulmonary	 valve	and	 the	 right	 ventricle	 and	 tricuspid	 valve	 are	 often	 developed	 poorly	 (American	Heart	Association,	2015).	In	these	patients	the	only	source	of	lung	blood	flow	is	the	patent	ductus	arteriosus	and	if	 this	closes	the	patient	experiences	severe	cyanosis,	and	 dies	 (American	 Heart	 Association,	 2015).	 Depending	 on	 the	 size	 of	 the	pulmonary	artery	and	 the	right	ventricle	a	complete	repair	of	 this	defect	 could	be	possible	 by	 placing	 a	 shunt	 between	 the	 aorta	 and	 the	 pulmonary	 artery.	 If	 the	pulmonary	artery	and	the	right	ventricle	were	too	small,	the	repair	would	then	be	to	connect	 the	 body	 veins	 directly	 to	 the	 pulmonary	 arteries	 (American	 Heart	Association,	 2015).	 These	 patients	 can	 also	 undergo	 the	 Glenn	 and	 Fontan	procedures	 if	necessary	 to	alleviate	symptoms	and	cyanosis.	Tricuspid	Atresia	 is	a	condition	 where	 no	 tricuspid	 valve	 is	 present.	 This	 gives	 a	 patient	 abnormal	circulation	and	causes	cyanosis.	Treatment	is	again	a	shunt	or	the	Glenn	and	Fontan	procedures	(American	Heart	Association,	2015).	
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Figure	3:	Heart	after	Completion	of	Fontan	Procedure.	The	left	side	of	the	heart	has	 been	 completely	 bypassed	 and	 now	 deoxygenated	 blood	 flows	 freely	 to	 the	lungs.	(Adapted	from	Asirvatham,	2008)		
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Figure	4:	Heart	at	Each	Palliative	Stage.	a)	Stage	1	is	the	Norwood	Procedure.	b)	Stage	 2	 is	 the	 Bi-Directional	 Glenn	 Shunt	 Procedure.	 c)	 Stage	 3	 is	 the	 Fontan	Procedure.	 d)	 Stage	 4	 is	 the	 closure	 of	 the	 fenestration.	 (Adapted	 from	 Fruitman,	2000)	
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Right	Ventricle	Outflow	Tract	Obstruction	(RVOTO)		 Right	ventricle	outflow	tract	obstruction,	is	an	obstruction	in	the	blood	flow	from	the	right	ventricle	of	the	heart	to	the	lungs.	While	RVOTO	can	occur	on	its	own,	is	more	commonly	seen	in	conjunction	with	another	condition	such	as	tetralogy	of	Fallot	(Nevil	Thomas	Adult	Congenital	Heart	Library,	2001).			 Tetralogy	of	Fallot		(Figure	5)	is	a	combination	of	four	defects;	a	ventricular	septal	defect,	right	ventricle	outflow	tract	obstruction,	right	ventricular	hypertrophy	or	 a	 thickening	 of	 the	muscles	 surrounding	 the	 lower	 right	 chamber	 of	 the	 heart,	and	 a	 displaced	 aorta	 that	 lies	 over	 the	 ventricular	 septal	 defect	 (National	 Heart,	Lung,	and	Blood	Institute,	2013).	Neonates	and	children	with	tetralogy	of	Fallot	are	prone	 to	 episodes	of	 cyanosis	 and	 is	 now	 treated	 in	 infancy	 to	prevent	 additional	health	complications.	The	palliative	care	as	a	neonate	is	the	placement	of	a	shunt	to	provide	 a	 temporary	 repair	 to	 the	 problem	 of	 poor	 blood	 flow	 to	 the	 lungs.	 This	technique	 is	 not	 widely	 used	 since	 most	 surgeons	 now	 prefer	 to	 perform	 the	complete	 repair	 as	 soon	 as	 possible	 (National	 Heart,	 Lung,	 and	 Blood	 Institute,	2013).	The	complete	repair	consist	in	the	closure	of	the	septal	defect,	and	either	the	opening	 or	 removal	 of	 the	 RVOTO,	 that	 sometimes	 requires	 the	 placement	 of	 a	prosthetic	 pulmonary	 conduit.	 This	 approach	 is	 now	 very	 successful,	 leading	 to	extremely	good	outcomes	(American	Heart	Association,	2015).	
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Figure	5:	Repaired	Tetralogy	of	Fallot.	Ventricular	septal	defect	is	closed	using	a	patch	and	the	RVOTO	is	opened	and	lung	flow	from	right	ventricle	to	lungs	is	repaired.	(Adapted	from	Diller	et.	al.,	2011)										
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Congenital Heart Disease and Thrombotic Events.  	 Children	 with	 congenital	 heart	 disease	 are	 at	 an	 increased	 risk	 for	thrombosis.	Data	shows	that	post-operative	complications	 involving	thrombosis	 in	children	 with	 congenital	 heart	 disease	 varies	 in	 the	 range	 of	 100/10,000	 and	3,500/10,000	incidences	reported	(Giglia	et.	al.,	2013).	This	is	relatively	high	when	the	 prevalence	 of	 thrombosis	 in	 pediatric	 CHD	 is	 compared	 to	 the	 prevalence	 of	thrombosis	 in	 the	 non-cardiac	 pediatric	 population.	 The	 non-cardiac	 pediatric	population	has	a	relatively	low	prevalence	of	thrombosis	at	20-50/10,000	hospital	admissions	 (Raffini	 et.	 al.,	 2009;	 Bouet	 et.	 al.,	 2009).	 The	 incidence	 is	 further	increased	 when	 the	 prevalence	 of	 symptomatic	 thrombosis	 is	 taken	 into	 account	giving	a	range	of	160-1,600/10,000	in	children	with	cancer	(Piovesan	et.	al.,	2014).		Children	 with	 cyanotic	 congenital	 heart	 diseases	 have	 differences	 in	 their	blood	compilation	and	coagulation	profiles	from	normal	children	leading	to	multiple	complications	such	as	high	incidence	of	intraoperative	hemorrhage,	and	high	rate	of		thrombosis	 in	 the	 postoperative	 period	 (Zabala	 et.	 al.,	 2015).	 Another	 study	conducted	 by	 Giglia	 et.	 al.	 also	 states	 that	 thrombosis	 has	 been	 recognized	 as	 a	condition	with	potentially	life-threatening	complications	in	children	with	congenital	heart	diseases,	especially	those	with	shunt-dependent	single	ventricles	and	Fontan	circulation.	 Their	 study	 found	 that	 with	 shunt-dependent	 single	 ventricles	 the	incidence	of	thrombosis	was	8-12%,	and	with	the	Fontan	circulation	the	incidence	was	higher	at	17-33%	(Giglia	et.	al.,	2013).		
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The	 findings	of	Giglia	et.	al.	 are	 further	 supported	by	a	 study	completed	by	Odegard	et.	al.	 that	 looked	at	 coagulation	profiles	 in	 children	with	hypoplastic	 left	heart	 syndrome	 (HLHS)	 through	 all	 three	 procedures.	 The	 study	 completed	 by	Odegard	et.	al.	found	that	children	with	single	ventricle	physiology,	either	before	or	after	 the	 Fontan	 procedure,	 appear	 to	 have	 the	 highest	 risk	 for	 thrombosis.	 This	study	concluded	that	coagulation	abnormalities	could	put	patients	at	a	higher	risk	for	 clotting	 or	 bleeding	 complications	 (Odegard	 et.	 al.,	 2002).	 Another	 study	completed	by	Odegard	et.	al.	 reported	 that	 there	were	significantly	 lower	 levels	of	both	pro-coagulation	and	anticoagulation	factors,	specifically	factor	VIII,	in	patients	through	the	completion	of	the	Fontan	procedure	(Odegard	et.	al.,	2009).	Though	the	deficiency	was	present	through	the	Fontan	procedure,	the	study	found	that	after	the	Fontan	the	levels	of	factor	VIII	increased.	The	researchers	in	this	study	thought	that	the	monitoring	of	increase	in	factor	VIII	after	the	Fontan	procedure	in	patients	could	help	 to	 indicate	 the	 patients	 at	 risk	 for	 thrombosispost-Fontan	 (Odegard	 et.	 al.,	2009).	
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Specific	Aims	and	Objectives		 There	 is	a	profound	 lack	of	research	regarding	thrombotic	complications	 in	children	 with	 congenital	 heart	 disease	 and	 prophylactic	 therapies	 for	 these	complications.	This	 study	aims	 to	 identify	 factors	 that	contribute	 to	 thrombosis	 in	children	 with	 surgical	 and	 non-surgical	 congenital	 heart	 disease	 to	 better	understand	 the	 incidences	 and	 the	 predictors	 for	 thrombosis	 in	 this	 high-risk	population.		 Using	 a	 sample	 of	 children	 with	 surgical	 and	 non-surgical	 CHD	 from	 the	Health	Care	Cost	and	Use	Project	Kid’s	 Inpatient	Database	the	specific	aims	of	 this	study	are:		1. To	 assess	 the	 incidence	 and	 predictors	 for	 thrombosis	 in	 children	with	surgical	 and	 non-surgical	 heart	 disease	 by	 performing	 a	 retrospective	analysis	 of	 the	 database.	 Some	 of	 the	 variables	 tested	 as	 predictors	included	age	group,	type	of	cardiac	lesion,	coagulopathy,	ECMO,	VAD,	AKI,	sepsis,	 elective	 hospital	 admission,	 Elixhauser	 co-morbidity	 score,	 and	length	of	stay.		2. To	 compare	 the	 incidence	 in	 children	with	 CHD	with	 another	 high-risk	non-cardiac	pediatric	population.	In	this	study	the	incidences	observed	in	CHD	 patients	 were	 compared	 with	 a	 control	 group	 of	 children	 with	cancer.	 As	 mentioned	 above	 the	 prevalence	 in	 non-cardiac	 pediatric	population	 is	 relatively	 low,	 but	 the	 prevalence	 of	 symptomatic	thrombosis	 in	 patients	 with	 cancer	 is	 between	 160/10,000	 to	
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1,600/10,000	 (Piovesan	 et.	 al.,	 2014)	 which	 is	 comparable	 to	 children	with	CHD	which	has	a	prevalence	of	thrombosis	between	100/10,000	and	3,500/10,000	incidences	reported	(Giglia	et.	al.,	2013).		By	completing	this	study,	the	goal	would	be	to	have	a	better	understanding	of	predictors	for	thrombotic	complications.	By	furthering	the	research	in	this	study	the	hope	 would	 be	 to	 better	 to	 define	 optimal	 prophylactic	 approaches	 to	 treating	thrombosis	based	on	the	predictors	for	thrombotic	complications.		
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METHODS			 The	 retrospective	analysis	was	performed	using	 the	2009	and	2012	Health	Care	Cost	and	Use	Project	(HCUP)	Kid’s	Inpatient	Databases	(KID).	The	KID	data	set	is	 a	 national	 database	 that	 encompasses	 more	 than	 100	 clinical	 and	 non-clinical	variables.	 The	 database	 has	 a	 range	 of	 hospitals	 that	 include	 specialty	 hospitals,	public	 hospitals,	 and	 academic	 medical	 centers.	 The	 size	 of	 the	 hospitals	 were	categorized	 by	 HCUP	 using	 the	 number	 of	 beds	 and	 this	 categorization	 was	 also	specific	to	hospital’s	location	and	teaching	status.	A	small	hospital	was	defined	as	1-99	 beds,	 medium	 was	 100-399	 beds,	 and	 large	 was	 more	 than	 400	 beds.	 Their	region,	 such	 as,	 Northeast,	 Mideast,	 South,	 and	 West,	 further	 categorized	 the	hospitals	in	the	database	(Health	Care	Cost	and	Use	Project	Kid’s	Inpatient	Database,	2009).	This	work	was	approved	by	the	International	Review	Board.		 Using	 the	 database	 and	 International	 Classification	 of	 Diseases,	 Ninth	Revision,	 Clinical	 Modification	 codes	 (IDC-9	 CM)	 diagnostic	 codes,	 neonates	 and	children	with	CHD	were	 identified	 for	 analysis.	 Each	 case	was	 reviewed	using	 the	IDC-9	 CM	 diagnostic	 codes	 and	 separated	 into	 surgical	 and	 non-surgical	 groups.	Cases	that	were	assigned	to	multiple	diagnostic	code	categories	were	excluded	from	the	 study.	 The	 surgical	 group	 included	 hospitalized	 CHD	 patients	 that	 underwent	cardiac	 surgery	 procedures	 such	 as,	 cardiac	 catheterization	 procedures,	 cardiac	surgery,	 or	 non-cardiac	 surgery.	 All	 other	 hospitalized	 CHD	 patients	 were	categorized	 into	 the	 non-surgical	 group.	 The	 cases	 were	 further	 sub-divided	 into	
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four	 additional	 groups	 looking	 at	 the	 type	 of	 lesion:	 septal	 defects	 (SD),	 single	ventricle	physiology	 (SVP),	 right	 ventricle	outflow	 tract	obstruction	 (RVOTO),	 and	left	ventricle	outflow	tract	obstruction	(LVOTO).			 Patient’s	 age	 and	 length	 of	 hospital	 stay	 were	 also	 assessed	 as	 factors	 for	increased	thrombosis	risk.	Each	patients	age	at	admission	was	categorized	into	one	of	five	age	groups:	neonates	(less	than	1	month	of	age),	1	to	12	months	old,	1	to	6	years	 old,	 6	 to	 12	 years	 old,	 and	 older	 than	 12	 years	 old.	 In	 addition	 to	 age	 and	length	 of	 stay,	 demographic	 information,	 co-morbidities,	 and	 outcomes	were	 also	identified.	 Using	 the	 ICD-9	 CM	 procedure	 codes	 the	 outcomes	 identified	 were:	mortality,	 acute	 kidney	 injury	 (AKI),	 sepsis,	 neurologic	 complications,	 thrombotic	complications,	extracorporeal	membrane	oxygenation	(ECMO)	use	in	neonates,	and	ventricular	 assist	 device	 (VAD)	 use	 in	 neonates.	 Thrombotic	 complications	 were	classified	by	the	ICD-9	CM	diagnostic	codes	and	defined	as	intravascular	thrombosis,	either	 venous,	 atrial,	 or	 intra-cardiac	 including	 shunts,	 cardioembolic	 strokes,	 or	pulmonary	 embolisms.	 To	 identify	 co-morbidities	 a	 combination	 of	 the	 ICD-9	 CM	diagnostic	codes	and	a	modified	Elixhauser	comorbidity	score	was	used.	 (Quan	et.	
al.,	2005)	The	primary	diagnostic	code	was	not	considered	a	complication,	as	it	was	the	reason	for	hospital	admission	not	a	result	of	the	hospital	stay.				
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Statistical	Analysis			 Propensity	 matched	 analysis	 and	 multivariable	 logistic	 regression	 analysis	were	used	to	determine	the	predictors	 for	 thrombosis.	All	data	are	presented	as	a	number	 and	 a	 percentage.	 Each	 group	 of	 surgical	 and	 non-surgical	 heart	 disease	children	 were	 further	 sub-divided	 into	 groups	 of	 those	 with	 thrombotic	complications	 and	 those	 without	 thrombotic	 complications.	 These	 groups	 were	compared	using	a	Chi-square	test	for	categorical	variables.		 Multivariable	logistic	regression	using	backward	selection	was	used	to	obtain	variables	associated	with	thrombosis.	A	pre-defined	univariate	was	used	with	cut	off	values	of	P<0.10	for	variable	inclusion	and	P>0.05	for	removal	from	the	model.	The	association	of	hospital	identification	with	the	incidence	of	thrombotic	complications	was	 evaluated	 after	 adjusting	 for	 cluster	 by	 center	 using	 hospital	 identification	number	by	using	a	logistic	regression	model	using	generalized	estimating	equations	(GEE).	 To	 assess	 the	 strength	 of	 the	 association	 between	 thrombosis	 and	 the	independent	 variables	 the	 cumulative	 area	 under	 the	 receiver	 operating	characteristic	(ROC)	curve	was	calculated.			 Furthering	 our	 statistical	 analysis	 a	 logistic	 regression	model	 was	 used	 to	identify	 demographic	 and	 co-morbidity	 (including	 Elixhauser	 score)	 variables	predicting	 surgical	 vs.	 non-surgical	 heart	 disease.	 From	 these	 variables	consequently	 a	 propensity	 score	 can	 be	 determined	 by	 completing	 a	 propensity-matched	analysis	 (Deb	et.	al.,	2015).	For	 the	propensity	score	model	 the	 following	characteristics	 were	 included:	 age,	 gender,	 elective	 hospital	 admission,	 type	 of	
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cardiac	 lesion,	 Elixhauser	 co-morbidity	 score,	 and	 length	 of	 stay.	 The	 propensity	matched	analysis	done	used	a	nearest-neighbor-1:1-greedy	matching	algorithm.	The	algorithm	 was	 applied	 to	 match	 children	 with	 surgical	 and	 non-surgical	 heart	disease	 on	 the	 basis	 of	 the	 logit	 of	 their	 propensity	 score.	 This	 matching	 was	completed	 using	 a	 caliper	width	 equal	 to	 0.2	 times	 the	 standard	 deviation	 of	 the	logit	 of	 their	 propensity	 score	 (Austin	 et.	 al.,	 2014;	 Austin,	 2011).	 The	 balance	 of	baseline	covariates	between	the	exposed	and	control	groups	in	the	matched	sample	was	assessed	using	standard	differences,	with	standardized	differences	of	less	than	0.1	 for	 each	 covariate.	 This	 test	 was	 completed	 to	 show	 that	 there	 was	 a	 good	balance	in	the	match	cohort	(Austin,	2009).		 As	 a	 secondary	 objective	 the	 incidence	 of	 thrombotic	 complications	 in	children	with	surgical	and	non-surgical	heart	disease	was	compared	with	a	matched	group	 of	 children	with	 cancer.	 A	 logistic	 regression	model	 to	 define	 demographic	and	 co-morbidity	 variables	 predicting	 surgical	 heart	 disease	 vs.	 cancer	 diagnosis	was	performed	with	the	same	methods	as	mentioned	previously.	After	this	analysis	was	completed	a	second	propensity-matched	analysis	was	completed	as	mentioned	above	using	 the	 same	 characteristics	 as	when	 comparing	 surgical	 vs.	 non-surgical	heart	disease.		 A	 P	 value	 of	 <0.05	 was	 considered	 statistically	 significant	 for	 all	 tests.	 All	reported	 values	 in	 this	 study	 are	 absolute	 values	measured	 from	 the	 data	 set.	 All	statistical	analyses	were	performed	using	STATA	version	14.1	for	Mac	OS.				 	 	
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RESULTS			 The	2009	and	2012	KID	HCUP	databases	included	6,386,928	children.	From	this	 database,	 274,583	 children	 were	 identified	 with	 CHD	 totaling	 to	 4%	 of	 the	database.	Of	the	274,583	CHD	patients;	27,492	or	10%	of	the	patients	had	surgical	heart	 disease	 and	 247,091	 or	 90%	had	 non-surgical	 heart	 disease.	 In	 the	 general	population	 of	 children	 with	 CHD	 the	 incidence	 of	 thrombotic	 complications	 was	found	to	be	0.28%.	The	incidence	of	thrombosis	became	was	3.62%.	in	children	with	surgical	 heart	 disease.	 For	 the	 children	 with	 non-surgical	 heart	 disease	 the	incidence	of	thrombosis	was	lower	at	0.85%	(P<0.001).			 The	 first	 propensity-matched	 analysis,	 using	 24,251	 children	with	 surgical	heart	 disease	 match	 with	 an	 equal	 number	 of	 children	 with	 non-surgical	 heart	disease,	found	that	the	incidence	of	thrombotic	complications	was	3.90%	in	children	with	 surgical	heart	disease	and	2.13%	 in	 children	with	non-surgical	heart	disease	(P<0.001).	In	the	second	propensity-matched	analysis,	children	with	surgical	heart	disease	were	matched	with	an	equal	number	of	children	with	cancer.	The	incidence	of	 thrombotic	 complications	was	 found	 to	 be	 significantly	 higher	 in	 children	with	surgical	heart	disease	at	3.75%	when	compared	to	1.19%	incidence	of	thrombosis	in	children	with	cancer.	Non-surgical	heart	disease	patients	also	had	a	higher	incidence	of	thrombosis	at	2.13%	when	compared	to	children	with	cancer	(P<0.001).	
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Figure	 6:	 Flow	 chart	 and	 description	 of	 the	 propensity-matched	 analysis.	 A	significant	difference	is	seen	between	patients	with	surgical	heart	disease	and	those	patients	 with	 non-surgical	 heart	 disease.	 There	 is	 also	 a	 significant	 difference	between	cancer	patients	and	patients	with	surgical	heart	disease.				
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Among	the	surgical	and	non-surgical	heart	disease	populations,	demographic	characteristics	 and	 outcomes	were	 compared	 between	 children	with	 and	without	thrombotic	complications.		
Table	1:	Characteristics	of	children	with	surgical	and	non-surgical	heart	
disease	diagnosed	with	a	thrombotic	complication	
	
Note.	Data	are	presented	as	number	 (%),	or	median	and	 interquartile	 range	 (IQR)	when	appropriate.					 		
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Furthering	the	comparison,	demographic	characteristics,	co-morbidities,	and	outcomes	 in	children	with	non-surgical	and	surgical	heart	disease	were	compared	using	 before	 and	 after	 propensity-match	 analysis.	 Seen	 in	 Tables	 2	 and	 3	 are	 the	results	of	the	multivariate	logistic	regression	analysis.			
Table	2:	Variables	obtained	from	multivariate	logistic	regression	analysis	
associated	with	thrombotic	complications	in	the	surgical	population		
	
Note.	Data	are	presented	as	B,	 regression	coefficient;	SE,	 standard	error;	OR,	odds	ratio;	95	CI,	95%	confidence	interval.		*	 Cumulative	 areas	 under	 the	 receiver	 operative	 characteristics	 (ROC)	 curve	 are	used	 to	 assess	 the	 accuracy	 of	 logistic	 regression	 model	 to	 predict	 thrombotic	complications		 	 	
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Table	3:	Variables	obtained	from	multivariate	logistic	regression	analysis	
associated	with	thrombotic	complications	in	the	non-surgical	population		
	
	
Note.	Data	are	presented	as	B,	 regression	coefficient;	SE,	 standard	error;	OR,	odds	ratio;	95	CI,	95%	confidence	interval.		*	 Cumulative	 areas	 under	 the	 receiver	 operative	 characteristics	 (ROC)	 curve	 are	used	 to	 assess	 the	 accuracy	 of	 logistic	 regression	 model	 to	 predict	 thrombotic	complications	
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From	the	multivariate	logistic	regression	analysis	of	the	surgical	population,	children	 less	 than	 1	 month	 old	 and	 children	 between	 1	 month	 to	 1	 year	 had	 a	significant	increased	risk	of	thrombotic	complications.	It	 is	also	observed	that	SVP,	RVOTO,	and	the	presence	of	a	coagulopathy	were	associated	with	an	increased	risk	of	 thrombotic	 complications	 in	 both	 non-surgical	 and	 surgical	 congenital	 heart	disease	populations.	Furthermore,	children	supported	with	ECMO	or	VAD,	and	those	who	 developed	 AKI	 or	 sepsis,	 also	 had	 an	 increased	 risk	 of	 thrombosis	 in	 both	surgical	 and	 non-surgical	 heart	 disease	 populations.	 In	 an	 attempt	 to	 better	understand	 why	 surgical	 heart	 disease	 was	 significantly	 higher	 than	 the	 non-surgical	heart	disease	the	type	of	lesions	were	compared	(Figure	7).	The	correlation	between	 the	 presence	 of	 a	 thrombotic	 complications	 and	mortality	 rate	 was	 also	compared	(Figure	8).		 In	a	graphical	representation	the	incidence	of	thrombotic	complications	was	significantly	higher	in	children	with	SVP	and	RVOTO	when	compared	to	those	with	septal	defects	and	LVOTO	(P<0.001)	(Figure	7).	The	presence	of	thrombotic	complications	was	associated	with	a	significant	increase	in	mortality	in	both	populations	(P<0.001)	(Figure	8).			
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Figure	7:	Incidence	of	thrombotic	complications	in	children	with	surgical	and	
non-surgical	 heart	 disease	 based	 on	 the	 type	 of	 lesion.	 Highest	 incidence	 of	thrombosis	 is	 seen	 in	 SVP	 and	 RVOTO	 for	 both	 surgical	 and	 non-surgical	 heart	disease	when	compared	to	septal	defects	and	LVOTO	aortic	arch	repair	(Ao).				
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Figure	8:	Mortality	in	children	with	surgical	or	non-surgical	heart	disease	with	
or	 without	 thrombotic	 complications.	 The	 mortality	 rate	 is	 increased	 in	 the	presence	of	a	thrombotic	complication	when	compared	to	controls.			 	
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DISCUSSION			 Upon	completion	of	the	retrospective	analysis,	we	observed	a	high	incidence	of	 thrombotic	 complications	 in	 children	 with	 CHD.	 We	 observed	 that	 when	compared	 to	 children	 with	 non-surgical	 heart	 disease	 and	 children	 with	 cancer,	those	 with	 surgical	 heart	 disease	 had	 a	 higher	 incidence	 of	 thrombosis	 reported.	Looking	further	we	also	reported	that	children	with	SVP	and	RVOTO	had	the	highest	incidence	 of	 thrombosis	 overall.	 This	 result	 is	 likely	 because	 children	 with	 SVP	remain	 with	 a	 non-physiologic	 palliative	 circulation	 throughout	 all	 the	 palliative	surgical	 stages,	 and	 will	 be	 implemented	 with	 a	 prosthetic	 conduit	 that	 require	adequate	 anticoagulation	 in	 order	 to	 avoid	 any	 thrombotic	 event,	 while	 children	with	RVOTO	will	become	non-cyanotic	with	a	congenital	heart	disease	fully	repaired	to	a	physiologic	circulation	after	the	surgery	(American	Heart	Association,	2015).		This	study	also	found	that	those	children	with	coagulopathy,	children	placed	on	 ECMO	 or	 VAD,	 children	 who	 developed	 postoperative	 complications	 such	 as	sepsis	or	AKI,	and	children	who	had	a	prolonged	length	of	stay	(LOS>20	days)	also	had	a	higher	risk	of	 thrombotic	complications	that	 lead	to	a	significant	 increase	 in	mortality	rates.			 In	 a	 study	 completed	 by	 Manlhiot	 et.	 al.	 a	 retrospective	 analysis	 was	performed	 using	 1542	 children	 undergoing	 cardiac	 surgical	 procedures	 with	 or	without	 cardiopulmonary	 bypass.	 The	 incidence	 of	 thrombosis	 in	 patients	 was	confirmed	 by	 diagnostic	 imaging.	 The	 study	 concluded	 that	 there	 was	 an	 11%	
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incidence	 of	 thrombosis	 (Manlhiot	et.	al.,	2011).	 In	 contrast,	we	 observed	 a	 lower	incidence	 of	 thrombotic	 complications	 with	 surgical	 heart	 disease	 at	 3.90%.	 The	difference	in	the	incidence	of	thrombotic	complications	can	be	explained	by	the	fact	that	we	 used	 a	 database	 that	 encoded	 for	 thrombotic	 complications	 as	means	 for	analysis.	 This	 means	 that	 we	 cannot	 account	 for	 center	 variability	 in	 systematic	surveillance	and	screening	for	the	incidence	of	a	thrombotic	event,	and	for	reporting	of	sub-clinical	thrombosis	in	our	patients.			In	 an	 additional	 study	 completed	 by	 Manlhiot	 et.	 al.,	 	 found	 that	 oxygen	saturation	of	 <85%,	previous	 thrombosis,	 history	of	 a	heart	 transplant,	 the	use	of	deep	hypothermic	circulatory	arrest,	 the	presence	of	a	central	venous	catheter	 for	>5	days,	and	postoperative	use	of	ECMO	and	VAD,	were	significantly	associated	with	a	 higher	 risk	 of	 thrombosis.	 Also	 supporting	 our	 findings	 they	 reported	 that	 a	prolonged	 LOS	 was	 an	 indicator	 for	 increased	 mortality	 and	 risk	 of	 thrombotic	complications.	 Lastly,	 the	 study	by	Manlhiot	et.	al.	 also	 showed	 that	 patients	with	single	 ventricle	 physiology	 had	 a	 higher	 risk	 of	 thrombotic	 complications	 at	 an	incidence	 rate	 of	 40%	 after	 initial	 palliative	 therapy,	 28%	 after	 the	 superior	cavopulmonary	 connection,	 and	 ultimately	 21%	 after	 the	 Fontan	 procedure	(Manlhiot	et.	al.,	2012).	The	results	of	our	study	are	in	concurrence	with	the	study	completed	 by	 Manlhiot	 et.	 al.	 As	 reported	 in	 previous	 studies,	 we	 found	 that	neonates	 with	 surgical	 heart	 disease	 had	 a	 significantly	 higher	 incidence	 of	thrombotic	complications.		
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The	multivariate	model	 in	our	study	 indicated	that	children	over	the	age	of	12	had	an	increased	risk	of	thrombotic	complications	for	children	with	non-surgical	heart	disease,	 indicating	that	age	was	a	predictor	 for	 thrombotic	complication.	We	believe	that	this	result	could	be	because	the	older	children	admitted	to	the	hospital	are	 likely	 children	 with	 marginal	 hemodynamic	 status,	 sometimes	 inadequate	chronic	 anticoagulation	 therapy,	 and	 other	 risk	 factors	 for	 thrombotic	complications.		In	 a	 longitudinal	 study	 performed	 by	 Odegard	 et.	 al.	 (2009),	 children	with	hypoplastic	left	heart	syndrome	had	a	significant	decrease	in	the	level	of	both	pro-coagulant	 and	 anticoagulant	 factors	 through	 the	 completion	 of	 the	 Fontan	procedure	 (Odegard	 et.	 al.,	 2009).	 In	 a	 recent	 study	 completed	 by	 Emani	 et.	 al.	(2013)	 thrombin	 generation,	 plasminogen	 activator	 inhibitor,	 and	 thrombin	activatable	 fibrinolysis	 inhibitor,	 were	 found	 to	 be	 significantly	 elevated	 in	 SVP	patients	experiencing	postoperative	thrombosis	(Emani	et.	al.,	2013).	While	there	is	a	consensus	that	there	is	a	relatively	high	thrombotic	complication	rate	before	and	after	 the	 Fontan	 procedure,	 there	 is	 distinct	 lack	 of	 consensus	 on	 the	thromboprophylatic	 strategy	 needed	 in	 these	 cases.	 Though	 new	 research	 from	Tomkiewicz	et.	al.	(2014)	 indicated	 that	a	 combination	of	antiplatelet	 therapy	and	anticoagulang	 thromboprophylaxis	 could	 be	 beneficial	 for	 patients	 who	 have	undergone	 the	 Fontan	 patients	 and	 are	 expeincing	 enhanced	 platelet	 activation,	endothelial	 injuries,	 increased	 thrombin	 formation,	 and	 impaired	 fibrinolysis	(Tomkiewicz-Pajak	et.	al.,	2014).	
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Another	 aspect	 of	 our	 study	 was	 to	 compare	 the	 incidence	 of	 thrombotic	complications	between	children	with	surgical	and	non-surgical	heart	disease	with	a	matched	group	of	children	with	cancer.	Previous	studies	have	shown	that	those	with	cancer	are	known	 to	have	a	higher	 incidence	of	 thrombotic	 complications	 ranging	from	2.1%-16%	symptomatic	events	to	40%	for	asymptomatic	events	with	varying	types	of	cancer	(Piovesan	et.	al.,	2014).	We	found	that	in	our	study	the	incidence	of	thrombosis	observed	in	the	cancer	population	was	not	significantly	different	that	of	those	with	congenital	heart	disease,	but	when	comparing	the	cancer	to	patients	with	surgical	 heart	 disease	 to	 those	with	 surgical	 heart	 disease	we	 found	 a	 significant	difference.		
Limitations		 While	 there	 were	 significant	 findings	 in	 our	 research,	 our	 study	 includes	some	 major	 	 limitations.	 Most	 hospitals	 do	 not	 systematically	 screen	 cardiac	patients	 for	 thrombosis,	 which	 means	 that	 the	 incidences	 reported	 is	 more	 than	likely	lower	than	what	it	would	be	if	hospitals	used	a	screening	process.	This	limits	our	ability	to	assess	incidences	of	thrombotic	complications.	The	national	database	used	to	complete	the	retrospective	chart	review,	HCUP	KID,	is	large	and	more	than	likely	 included	missing	data,	miscoded	diagnosis,	 and	miscoded	procedures.	Many	children	 had	 overlapping	 ICD-9-CM	 codes,	 which	 may	 have	 made	 us	 misclassify	some	cases	as	we	used	the	codes	to	classify	patients	into	different	diagnostic	groups.	The	HCUP	database	is	administrative	data	and	only	includes	clinically	detected	and	
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coded	 thrombotic	 complications.	 A	 study	 conducted	 by	 Wright	 et.	 al.	 (2011),	observed	that	when	using	an	administrative	database,	like	HCUP,	that	the	incidence	of	 thrombosis	 in	 the	 pediatric	 population	was	 often	miscalculated	 (Wright	 et.	 al.,	2011).		Using	the	HCUP	KID’s	database	patient	history	is	only	seen	as	it	 is	reported	and	 a	 lot	 of	 details	 could	 have	 been	 missing.	 For	 example,	 we	 were	 unable	 to	establish	 causality	 and	 any	 time	 related	 relationship	 between	 the	 hospital	admission	 and	 the	 thrombotic	 complications,	 as	 we	 were	 only	 able	 to	 see	 the	outcomes.	 In	 some	patients	 cases	we	were	unable	 to	determine	 if	 the	patient	was	admitted	 with	 thrombosis	 or	 if	 they	 developed	 thrombosis	 during	 the	 course	 of	their	 hospitalization.	This	meant	 that	we	were	unable	 to	 assess	how	 treatment	 of	the	 thrombosis	 was	 applied	 to	 these	 patients,	 when	 they	 were	 diagnosed,	 how	central	 venous	 access	 contributed	 to	 the	 thrombotic	 complication	 risk.	 In	 other	words,	we	were	unable	 to	assess	 the	entirety	of	 the	 incidence	of	 thrombosis	 from	diagnosis	through	treatment.	For	this	reason	further	studies	are	needed	to	validate	the	predictive	model	found	in	this	study	through	institutional	databases.		
Future	Directions			 As	reported	by	Faraoni	et.	al.	(2015),	there	is	an	independent	association	of	increased	 hospital	 cost	 with	 four	 categories;	 hospital	 bed	 size,	 the	 number	 of	procedures	 performed,	 hospital	 length	 of	 stay,	 and	 the	 incidence	 of	 major	complications	(Faraoni	et.	al.,	2015).	Our	study	found	that	the	 longer	the	 length	of	
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stay	(>20	days)	was	a	predictor	for	thrombotic	complications	which	would	increase	hospital	costs	according	to	the	study	by	Faraoni	et.	al.	Understanding	the	predictors	for	thrombotic	complications	could	potentially	reduce	hospital	costs	by	reducing	the	incidence	 rate.	 The	 study	 conducted	 by	 Faraoni	 et.	 al.	 (2015)	 also	 found	 that	children	 with	 CHD	 consume	 23%	 of	 national	 hospital	 resources,	 but	 they	 only	account	for	4%	of	hospitalizations.(Faraoni	et.	al.,	2015).	Further	studies	are	needed	to	 better	 define	 the	 optimal	 prophylactic	 approach	 and	 to	 better	 monitor	 the	response	 to	 the	 prophylactic	 therapies.	 The	 next	 part	 of	 the	 project	 would	 to	examine	 at	 the	 incidence	 of	 thrombosis	 at	 a	 more	 local	 level	 by	 completing	 a	retrospective	chart	review	of	patients	at	Boston	Children’s	Hospital.	In	addition	to	a	retrospective	 chart	 review,	 a	 prospective	 analysis	 of	 patients’	 coagulation	 factors	will	be	completed	to	further	investigate	the	theory	that	coagulation	factors	may	be	a	predictor	 for	 thrombotic	 complications	 as	 indicated	 in	 the	 study	 completed	 by	Odegard	et.	al.	(2009).		Thromboprophylaixis	 for	 SVP	 patients	 both	 before	 and	 after	 the	 Fontan	procedure	was	a	top	research	priority	according	to	a	report	from	the	National	Heart,	Lung	 and	 Blood	 Institute/National	 Institutes	 of	 Health	 Working	 Group	 on	Thrombosis	 in	Pediatric	Cardiology	and	Congenital	Heart	Disease	 (National	Heart,	Lung	and	Blood	Institiute,	2014).	A	trial	completed	by	Monagle	et.	al.	concluded	that	there	was	no	advantage	to	using	antiplatelet	 therapy	over	anticoagulation	therapy	or	vice	versa	(Monagle	et.	al.,	2011).	With	this	information,	the	therapies	should	be	tailored	 to	 an	 individuals	 response	 as	 a	 prophylactic	 treatment	 option	 for	 those	
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patients	 with	 congenital	 heart	 disease	 and	 complications	 with	 their	 coagulation	factors.			 Investigating	 the	 impact	 that	 congenital	 heart	 disease	with	 single	 ventricle	physiology	 and	 related	 incidences	 of	 thrombosis	 has	 on	 quality	 of	 life	 is	 another	aspect	 that	will	 be	 included	 in	 the	 next	 part	 of	 the	 project.	 A	 study	 completed	by	Idorn	 et.	 al.	 found	 that	 the	 quality	 of	 life	 is	 reduced	 in	 Fontan	 children	 when	comparing	them	to	normal	children	(Idorn	et.	al.,	2013).	This	study	also	found	that	over	 the	age	of	16	 the	quality	of	 life	was	only	diminished	physically	where	as	 the	younger	 children	 experienced	 diminished	 quality	 of	 life	 both	 physically	 and	psychosocially	as	well.	Lastly,	this	study	found	that	cognitive	speed	was	significantly	reduced	in	patients	of	all	ages	(Idorn	et.	al.,	2013).	Supporting	the	finding	of	Idorn	
et.	al.,	a	study	by	Uzark	et.	al.	found	that	children	with	cardiovascular	diseased	has	a	lower	perceived	quality	 of	 life	when	 compared	 to	 children	who	were	healthy	 and	those	 with	 severe	 cardiovascular	 disease	 have	 worse	 physical	 and	 psychosocial	quality	of	life	(Uzark	et.	al.,	2015).		
Conclusions		 In	conclusion,	our	study	confirmed	that	children	with	both	surgical	and	non-surgical	 heart	 disease	 have	 an	 increased	 risk	 for	 thrombotic	 complications	 when	compared	 to	other	pediatric	populations.	The	 risk	 for	 thrombotic	 complications	 is	significantly	increased	when	a	patient	has	a	cyanotic	heart	disease.	The	highest	risk	
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for	 thrombotic	 complications	 is	 seen	 in	 patients	who	 have	 the	 presence	 of	 single	ventricle	physiology.		
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